The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation

The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation

Inflammatory physiology has been linked to behavioral and emotional symptoms in a variety of contexts and experimental paradigms. Hematopoietic cell transplantation (HCT) represents an intersection of significant immune dysregulation and psychosocial stress, and this biobehavioral relationship can i...

Full description

Bibliographic Details
Main Authors: Cole, S.W (Author), Drobyski, W.R (Author), Hillard, C.J (Author), Johnson, B.D (Author), Knight, J.M (Author), Raison, C.L (Author), Szabo, A. (Author), Taylor, M.R (Author), Zhu, F. (Author)
Format: Article
Language:English
Published: Elsevier Inc. 2022
Subjects:
Cancer
Cytokines
Hematopoietic cell transplantation
Patient reported outcomes
Online Access:View Fulltext in Publisher

Similar Items

Similar Items